0

CYCLOPHOSPHAMIDE از شرکت HIKMA

تصویر پیدا نشد !

اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است

CYCLOPHOSPHAMIDE از شرکت HIKMA

New Drug Application (NDA): 203856

Company: HIKMA

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
CYCLOPHOSPHAMIDE CYCLOPHOSPHAMIDE 25MG CAPSULE;ORAL Prescription

AB

Yes No
CYCLOPHOSPHAMIDE CYCLOPHOSPHAMIDE 50MG CAPSULE;ORAL Prescription

AB

Yes Yes
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
09/16/2013 ORIG-1 Approval

Type 5 – New Formulation or New Manufacturer

STANDARD

Label (PDF)

Letter (PDF)

Review

Summary Review (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203856s000lbl.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/203856Orig1s000ltr.pdf
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/203856Orig1s000TOC.cfm
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/203856Orig1s000SumR.pdf

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
09/26/2019 SUPPL-3 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/203856s003lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/203856Orig1s003ltr.pdf

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
09/26/2019 SUPPL-3

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/203856s003lbl.pdf
09/16/2013 ORIG-1 Approval

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/203856s000lbl.pdf

CYCLOPHOSPHAMIDE

CAPSULE;ORAL; 25MG

TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
CYCLOPHOSPHAMIDE CYCLOPHOSPHAMIDE 25MG CAPSULE;ORAL Prescription No AB 207014 ANI PHARMS
CYCLOPHOSPHAMIDE CYCLOPHOSPHAMIDE 25MG CAPSULE;ORAL Prescription No AB 211608 CIPLA
CYCLOPHOSPHAMIDE CYCLOPHOSPHAMIDE 25MG CAPSULE;ORAL Prescription Yes AB 203856 HIKMA
CYCLOPHOSPHAMIDE CYCLOPHOSPHAMIDE 25MG CAPSULE;ORAL Prescription No AB 209872 STI PHARMA LLC

CAPSULE;ORAL; 50MG

TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
CYCLOPHOSPHAMIDE CYCLOPHOSPHAMIDE 50MG CAPSULE;ORAL Prescription No AB 207014 ANI PHARMS
CYCLOPHOSPHAMIDE CYCLOPHOSPHAMIDE 50MG CAPSULE;ORAL Prescription No AB 211608 CIPLA
CYCLOPHOSPHAMIDE CYCLOPHOSPHAMIDE 50MG CAPSULE;ORAL Prescription Yes AB 203856 HIKMA
CYCLOPHOSPHAMIDE CYCLOPHOSPHAMIDE 50MG CAPSULE;ORAL Prescription No AB 209872 STI PHARMA LLC
بخوانید  ACCUPRIL از شرکت PFIZER PHARMS
برچسب‌ها:

نظرات کاربران